United Health Products (UEEC) Non-Current Deffered Revenue (2022 - 2023)
United Health Products' (UEEC) quarterly Non-Current Deffered Revenue came in at $132281.0 in Q2 2023, down 29.51% quarter-over-quarter from $187668.0 in Q1 2023.
Powered by 
Analysis
United Health Products (UEEC) Non-Current Deffered Revenue (2022 - 2023) Analysis & Trends
United Health Products (UEEC) has reported Non-Current Deffered Revenue for 2 consecutive years, with $132281.0 the latest figure, recorded in Q2 2023.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $132281.0 in Q2 2023; TTM through Jun 2023 was $132281.0, a N/A change from a year earlier, with the FY2022 full-year figure at $243039.0, changed N/A from the prior year.
- Non-Current Deffered Revenue was $132281.0 for Q2 2023 at United Health Products, down from $187668.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $250000.0 in Q3 2022 and troughed at $132281.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | - |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 13.90 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | - |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | - |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | - |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 132,281.00 |
| Mar 31, 2023 | 187,668.00 |
| Dec 31, 2022 | 243,039.00 |
| Sep 30, 2022 | 250,000.00 |